Timothy Sullivan - May 3, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Chief Financial Officer
Signature: /s/ David Watson, attorney-in-fact for Timothy Sullivan
Stock symbol: APLS
Transactions as of: May 3, 2023
Transactions value $: $0
Form type: 4
Date filed: 5/3/2023, 04:22 PM
Previous filing: Apr 20, 2023
Next filing: Jun 6, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Gift	$0	-20K	-20.47%	$0.00	77.7K	May 3, 2023	Direct
transaction	APLS	Common Stock	Gift	$0	+20K	+55.2%	$0.00	56.2K	May 3, 2023	Indirect Owner (The Timothy E Sullivan Irrevocable Trust of 2023)	F1

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On May 3, 2023, the reporting person transferred 20,000 shares to The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.